FOXM1 and rhabdoid tumor: The in vivo effect was observed at a dose previously shown to be effective in rhabdoid tumor models.13 The tissue concentration of the compound was presumably lower than that having been effective in vitro, explaining the lack of effect on Ki-67 and FOXM1 positivity.